• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芬维林的多颗粒型双相胃滞留型漂浮药物传递系统的制剂与评价。

Formulation and evaluation of multiple tablets as a biphasic gastroretentive floating drug delivery system for fenoverine.

机构信息

Centre for Biopharmaceutics and Pharmacokinetics, University College of Pharmaceutical Sciences, Kakatiya University, Warangal-506009 (A.P.), India.

出版信息

Acta Pharm. 2010 Mar;60(1):89-97. doi: 10.2478/v10007-010-0001-3.

DOI:10.2478/v10007-010-0001-3
PMID:20228043
Abstract

A biphasic gastroretentive drug delivery system of fenoverine was developed to maintain constant plasma concentration. The delivery system consisted of a loading-dose tablet and a floating multiple matrix tablet prepared by the direct compression process. The drug release from biphasic GRDDS in 0.1 mol L(-1) HCl and SGF (enzyme free) was sustained over 12 h with buoyant properties. Stability studies showed no significant change in dissolution profiles (f2 value > 50). Based on the release kinetics, it can be concluded that the floating multiple matrix tablet containing HPMC was a particularly suitable gastroretentive drug delivery system with a zero-order release profile.

摘要

开发了一种芬维 A 的双相胃滞留药物传递系统,以维持稳定的血浆浓度。该传递系统由负荷剂量片剂和通过直接压缩工艺制备的漂浮型多基质片剂组成。双相 GRDDS 在 0.1 mol/L HCl 和 SGF(无酶)中的药物释放可持续 12 小时以上,并具有漂浮性能。稳定性研究表明,溶出曲线无明显变化(f2 值>50)。根据释放动力学,可以得出结论,含有 HPMC 的漂浮型多基质片剂是一种特别适合的胃滞留药物传递系统,具有零级释放特征。

相似文献

1
Formulation and evaluation of multiple tablets as a biphasic gastroretentive floating drug delivery system for fenoverine.芬维林的多颗粒型双相胃滞留型漂浮药物传递系统的制剂与评价。
Acta Pharm. 2010 Mar;60(1):89-97. doi: 10.2478/v10007-010-0001-3.
2
Formulation development and in-vitro evaluation of gastroretentive drug delivery system of loxoprofen sodium: A natural excipients based approach.洛索洛芬钠胃滞留型给药系统的制剂开发及体外评价:基于天然辅料的方法。
Pak J Pharm Sci. 2021 Jan;34(1):57-63.
3
Design and evaluation of floating multi-layer coated tablets based on gas formation.基于气体形成的漂浮多层包衣片的设计与评价
Eur J Pharm Biopharm. 2008 May;69(1):255-63. doi: 10.1016/j.ejpb.2007.09.013. Epub 2007 Oct 1.
4
Physiological relevant in vitro evaluation of polymer coats for gastroretentive floating tablets.用于胃滞留漂浮片的聚合物包衣的生理相关体外评价
Eur J Pharm Biopharm. 2014 Nov;88(3):778-86. doi: 10.1016/j.ejpb.2014.07.009. Epub 2014 Jul 31.
5
Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.基于亲水性聚合物的载茶碱胃滞留漂浮片:制备与体外评价
Pak J Pharm Sci. 2009 Apr;22(2):155-61.
6
Formulation and evaluation of controlled release antibiotic biodegradable implants for post operative site delivery.用于术后部位递送的控释抗生素可生物降解植入物的制剂和评价。
Acta Pharm. 2010 Mar;60(1):111-7. doi: 10.2478/v10007-010-0005-z.
7
Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.双氯芬酸钠缓释片制剂的制备及体外评价
Farmaco. 2005 Feb;60(2):171-7. doi: 10.1016/j.farmac.2004.10.001. Epub 2005 Jan 7.
8
Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl.盐酸美贝维林胃滞留漂浮型骨架片和漂浮筏系统的处方、释放特性及生物利用度研究
Drug Des Devel Ther. 2017 Apr 3;11:1081-1093. doi: 10.2147/DDDT.S131936. eCollection 2017.
9
Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin.用于氧氟沙星的新型缓释、可膨胀且生物黏附的胃滞留药物递送系统。
Int J Pharm. 2006 Jun 19;316(1-2):86-92. doi: 10.1016/j.ijpharm.2006.02.038. Epub 2006 Mar 29.
10
Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.塑料、疏水性和亲水性聚合物作为控释药物递送基质的比较评价。
J Pharm Pharm Sci. 2003 May-Aug;6(2):282-91.

引用本文的文献

1
Dual drug release electrospun core-shell nanofibers with tunable dose in the second phase.具有第二阶段剂量可调的双药释放电纺核壳纳米纤维。
Int J Mol Sci. 2014 Jan 8;15(1):774-86. doi: 10.3390/ijms15010774.